Pharmafile Logo
Pharmafocus logo
Advanced Search

Kings College London

Showing 5 posts of 5 posts found.

800px-blausen_0704_parkinsonsdisease

Scientists at King’s College London identify early signs of Parkinson’s disease

June 20, 2019
Research and Development King's College London, Kings College London, Parkinson's disease, pharma, serotonin

Scientists at King’s College London say they have identified the earliest signs of Parkinson’s disease in the brain – 15 …

News
ritalin-sr-20mg-1000x1000

Darknet sales of prescription psychiatric drugs increasing in the UK

February 27, 2019
Research and Development, Sales and Marketing King's College London, Kings College London, University of Kent, darknet, pharma

Research from the University of Kent and King’s College London has revealed that UK sales of prescription psychiatric drugs, including …

News
800px-t_lymphocyte_16760076824

KCL researchers find link between overactive immune system and Chronic Fatigue Syndrome/ ME

December 20, 2018
Research and Development CFS, KCL, King's College London, Kings College London, ME

Chronic fatigue syndrome (CFS) or Myalgic encephalomyelitis (ME) may be caused by an overactive immune system, according to researchers at …

News
medicinal_cannabis_uk_review

CBD dampens activity in brain regions associated with psychosis, study shows

August 30, 2018
Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study

Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …

News
Professor John Weinman image

Addressing the adherence gap

March 30, 2015
Research and Development, Sales and Marketing AstraZeneca, Kings College London, Professor John Weinman, adherence

Poor medication use in patients with long-term health conditions is widely recognised as a global problem that urgently needs to …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024